Advertisement
UK markets open in 1 hour 2 minutes

  • NIKKEI 225

    38,384.01
    +831.85 (+2.22%)
     

  • HANG SENG

    17,186.02
    +357.09 (+2.12%)
     

  • CRUDE OIL

    83.50
    +0.14 (+0.17%)
     

  • GOLD FUTURES

    2,341.10
    -1.00 (-0.04%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,621.30
    +187.47 (+0.35%)
     

  • CMC Crypto 200

    1,438.30
    +23.54 (+1.66%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine

Reuters
·1-min read
FILE PHOTO: The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company's listing at the NYSE in New York

(Reuters) - Johnson & Johnson <JNJ.N> has signed a manufacturing deal for its coronavirus vaccine candidate with Grand River Aseptic Manufacturing Inc, the contract manufacturing organization said on Friday.

Michigan-based GRAM will manufacture the healthcare conglomerate's SARS-CoV-2 vaccine candidate, which is being developed with part funding from the U.S. government, and provide finished vials.

Earlier in the week, J&J launched a late-stage trial of its experimental single-shot COVID-19 vaccine and said its expects results of the trial by year end or early next year.

J&J, which is readying its supply chain to start distribution as soon as it gets FDA's approval, expects to manufacture as many as 1 billion doses in 2021.

(Reporting By Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)